A NEW ERA OF VACCINE TECHNOLOGY pinkeye MORAXELLA BOVIS | MORAXELLA BOVOCULI BENEFITS OF CUSTOM MADE VACCINES: • Utilize multiple isolates to develop a unique combination product • Potential for significant cost savings on vaccine & labor • Keep preventative health program up to date using most current isolates • Mirror the real-world disease challenge by using specific disease strains • Available with DOCUVAC® vaccination compliance tool • Easy handling, excellent syringeability • Available in SOLIDOSE dual-dose implantable format • Approved for 21 day pre-slaughter withdrawal Newport Laboratories utilizes cutting-edge PINPOINT Technologies to create Custom Made Vaccines targeting your specific needs. From the latest in isolate analysis and selection techniques to proprietary manufacturing and adjuvanting systems, our Custom Made Vaccines are the epitome of science-based vaccine technology. Call Newport Laboratories today and put Custom Made Vaccines to work for you. 800-220-2522 | www.newportlabs.com Custom Made Vaccines are sold exclusively through veterinarians. ISO 9001:2008 Certified 1520 Prairie Drive | Worthington, MN 56187 800-220-2522 | f 507-372-2565 [email protected] | www.newportlabs.com References: 1. Snowder GD, Van Vleck LD, Cundiff LV and Bennett DL. Genetic environmental factors associated with incidence of infectious bovine keratoconjunctivitis in preweaned beef calves. J. Anim. Sci. 2005. 83:507-518. ®The Newport Laboratories Logo, DOCUVAC and PINPOINT are registered trademarks and SMFACS is a service mark of Newport Laboratories, Inc. All other marks belong to their respective owners. ©2013 Newport Laboratories, Inc., Worthington, MN. All rights reserved. NL4801 (10/13) MORAXELLA BOVIS | MORAXELLA BOVOCULI pinkeye A NEW ERA OF VACCINE TECHNOLOGY CUSTOM MADE VACCINES: Pinkeye (infectious bovine keratoconjunctivitis) associated with Moraxella bovis and Custom Made Vaccines are manufactured using the specific disease causing Moraxella bovoculi is a major factor affecting cattle health and performance. Calves organism(s) circulating in your herd or the immediate area. Newport Laboratories suffering from pinkeye weigh an average of 19.6 lbs less than healthy calves at utilizes cutting-edge PINPOINT® diagnostic and production technologies to weaning.1 Pinkeye associated with M. bovoculi is becoming a year-round problem. create a pinkeye vaccine targeting your specific needs. Pinkeye costs producers an estimated $150 million every year due to decreased Newport Laboratories’ traditional and molecular diagnostics help to identify weight gain, decreased milk production, and treatment costs. Additionally, affected and genetically analyze the organisms that are causing disease in your herd(s). animals are often heavily discounted by buyers. Our Food Animal Care Specialists (FACSSM) will then help you determine which isolate(s) to include in your Custom Made Vaccine. STRAIN VARIATION: Strain variation is an ongoing challenge when vaccinating for pinkeye with a SAFETY PROTOCOLS: commercial product. Newport Laboratories’ Custom Made Vaccines are manufactured following USDA approved production outlines. All of our Custom Made Vaccines are subject to •Commercial Mor. bovis products only contain specific strains that may or strict safety and sterility testing as required by the USDA in the 9CFR (Code of Federal Regulations). may not be the same strains your cattle are facing. •Commercial products do not contain M. bovoculi. DELIVERY FORMATS: These two factors make pinkeye a perfect candidate for a Custom Made Vaccine. BVC RTX 12-1923-5 booster dose to be administered to the animal at the same time. The booster BVC RTX 10-1249-4 BVC RTX 10-2774-1 Moraxella bovoculi Gene Sequencing Shows Strain Variation at the C-Terminus of RTX Toxin BVC RTX 11-2274-2 Analysis performed by Newport Laboratories. Data on file. BVC RTX 11-2274-3 BVC RTX 11-2674-3 BVC RTX 12-1923-1 BVC RTX 10-2774-3 Moraxella bovoculi reference BVC RTX 10-1249-3 BVC RTX 10-2774-2 BVS RTX 10-2774-4 BVS RTX 11-2674-4 BVS RTX 12-1923-2 Moraxella bovis reference BVS RTX 11-2274-1 BVS RTX 11-2274-4 14.5 14 12 10 8 6 4 Nucleotide Substitution per 100 residues 2 0 dose is programmed to release antigen for up to 2-3 weeks after administration. NON-ADJACENT HERD USE: Custom Made Vaccines can be used at multiple production sites and with multiple clients through USDA Non-Adjacent Herd Use approval. This allows BVC RTX 10-1249-2 BVS RTX 11-2674-2 Custom Made Vaccines are available as traditional liquid doses or in the SOLIDOSE® dual-dose implantable format. SOLIDOSE allows the initial dose and BVC RTX 11-2674-1 veterinarians greater flexibility with their Custom Made Vaccine. Newport Moraxella bovis A NEW ERA OF VACCINE TECHNOLOGY pinkeye MORAXELLA BOVIS | MORAXELLA BOVOCULI DISEASE IMPACT: Laboratories will assist in this process and file the appropriate forms with state veterinarians for approval. CUSTOM MADE VACCINES: Pinkeye (infectious bovine keratoconjunctivitis) associated with Moraxella bovis and Custom Made Vaccines are manufactured using the specific disease causing Moraxella bovoculi is a major factor affecting cattle health and performance. Calves organism(s) circulating in your herd or the immediate area. Newport Laboratories suffering from pinkeye weigh an average of 19.6 lbs less than healthy calves at utilizes cutting-edge PINPOINT® diagnostic and production technologies to weaning.1 Pinkeye associated with M. bovoculi is becoming a year-round problem. create a pinkeye vaccine targeting your specific needs. Pinkeye costs producers an estimated $150 million every year due to decreased Newport Laboratories’ traditional and molecular diagnostics help to identify weight gain, decreased milk production, and treatment costs. Additionally, affected and genetically analyze the organisms that are causing disease in your herd(s). animals are often heavily discounted by buyers. Our Food Animal Care Specialists (FACSSM) will then help you determine which isolate(s) to include in your Custom Made Vaccine. STRAIN VARIATION: Strain variation is an ongoing challenge when vaccinating for pinkeye with a SAFETY PROTOCOLS: commercial product. Newport Laboratories’ Custom Made Vaccines are manufactured following USDA approved production outlines. All of our Custom Made Vaccines are subject to •Commercial Mor. bovis products only contain specific strains that may or strict safety and sterility testing as required by the USDA in the 9CFR (Code of Federal Regulations). may not be the same strains your cattle are facing. •Commercial products do not contain M. bovoculi. DELIVERY FORMATS: These two factors make pinkeye a perfect candidate for a Custom Made Vaccine. BVC RTX 12-1923-5 booster dose to be administered to the animal at the same time. The booster BVC RTX 10-1249-4 BVC RTX 10-2774-1 Moraxella bovoculi Gene Sequencing Shows Strain Variation at the C-Terminus of RTX Toxin BVC RTX 11-2274-2 Analysis performed by Newport Laboratories. Data on file. BVC RTX 11-2274-3 BVC RTX 11-2674-3 BVC RTX 12-1923-1 BVC RTX 10-2774-3 Moraxella bovoculi reference BVC RTX 10-1249-3 BVC RTX 10-2774-2 BVS RTX 10-2774-4 BVS RTX 11-2674-4 BVS RTX 12-1923-2 Moraxella bovis reference BVS RTX 11-2274-1 BVS RTX 11-2274-4 14.5 14 12 10 8 6 4 Nucleotide Substitution per 100 residues 2 0 dose is programmed to release antigen for up to 2-3 weeks after administration. NON-ADJACENT HERD USE: Custom Made Vaccines can be used at multiple production sites and with multiple clients through USDA Non-Adjacent Herd Use approval. This allows BVC RTX 10-1249-2 BVS RTX 11-2674-2 Custom Made Vaccines are available as traditional liquid doses or in the SOLIDOSE® dual-dose implantable format. SOLIDOSE allows the initial dose and BVC RTX 11-2674-1 veterinarians greater flexibility with their Custom Made Vaccine. Newport Moraxella bovis A NEW ERA OF VACCINE TECHNOLOGY pinkeye MORAXELLA BOVIS | MORAXELLA BOVOCULI DISEASE IMPACT: Laboratories will assist in this process and file the appropriate forms with state veterinarians for approval. A NEW ERA OF VACCINE TECHNOLOGY pinkeye MORAXELLA BOVIS | MORAXELLA BOVOCULI BENEFITS OF CUSTOM MADE VACCINES: • Utilize multiple isolates to develop a unique combination product • Potential for significant cost savings on vaccine & labor • Keep preventative health program up to date using most current isolates • Mirror the real-world disease challenge by using specific disease strains • Available with DOCUVAC® vaccination compliance tool • Easy handling, excellent syringeability • Available in SOLIDOSE dual-dose implantable format • Approved for 21 day pre-slaughter withdrawal Newport Laboratories utilizes cutting-edge PINPOINT Technologies to create Custom Made Vaccines targeting your specific needs. From the latest in isolate analysis and selection techniques to proprietary manufacturing and adjuvanting systems, our Custom Made Vaccines are the epitome of science-based vaccine technology. Call Newport Laboratories today and put Custom Made Vaccines to work for you. 800-220-2522 | www.newportlabs.com Custom Made Vaccines are sold exclusively through veterinarians. ISO 9001:2008 Certified 1520 Prairie Drive | Worthington, MN 56187 800-220-2522 | f 507-372-2565 [email protected] | www.newportlabs.com References: 1. Snowder GD, Van Vleck LD, Cundiff LV and Bennett DL. Genetic environmental factors associated with incidence of infectious bovine keratoconjunctivitis in preweaned beef calves. J. Anim. Sci. 2005. 83:507-518. ®The Newport Laboratories Logo, DOCUVAC and PINPOINT are registered trademarks and SMFACS is a service mark of Newport Laboratories, Inc. All other marks belong to their respective owners. ©2013 Newport Laboratories, Inc., Worthington, MN. All rights reserved. NL4801 (10/13) MORAXELLA BOVIS | MORAXELLA BOVOCULI pinkeye A NEW ERA OF VACCINE TECHNOLOGY
© Copyright 2024 ExpyDoc